Woźniak, Grzegorz https://orcid.org/0000-0003-1949-8606
Rutkowski, Tomasz https://orcid.org/0000-0003-2735-5664
Majewski, Wojciech https://orcid.org/0000-0002-4000-1716
Napieralska, Aleksandra https://orcid.org/0000-0002-7390-9165
Wydmański, Jerzy https://orcid.org/0000-0002-2879-3781
Czarniecka, Agnieszka https://orcid.org/0000-0003-1249-7205
Szymczyk, Cezary https://orcid.org/0000-0001-9225-411X
Bekman, Adam https://orcid.org/0000-0002-6378-8013
Kaniszewska Dorsz, Żaneta
Latusek, Tomasz https://orcid.org/0000-0001-7930-5197
Maciejewski, Bogusław https://orcid.org/0000-0002-6349-7435
Article History
Received: 11 May 2024
Accepted: 20 January 2025
First Online: 8 February 2025
Declarations
:
: The authors declare no competing interests.
: The study was approved by the Ethics Committee of Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland (protocol code KB/430-70/23). Also pilot group study protocol and consent to participate was accepted in 2003 by the Ethics Committee of Maria Sklodowska-Curie Institute of Oncology, Gliwice. All study subjects or their legal guardian(s) had given informed consent to participate in study and treatment.